Circovirus Hepatitis Infection in Heart-Lung Transplant Patient, France

Emerg Infect Dis. 2023 Feb;29(2):286-293. doi: 10.3201/eid2902.221468. Epub 2023 Jan 3.

Abstract

In March 2022, a 61-year-old woman in France who had received a heart-lung transplant sought treatment with chronic hepatitis mainly characterized by increased liver enzymes. After ruling out common etiologies, we used metagenomic next-generation sequencing to analyze a liver biopsy sample and identified an unknown species of circovirus, tentatively named human circovirus 1 (HCirV-1). We found no other viral or bacterial sequences. HCirV-1 shared 70% amino acid identity with the closest known viral sequences. The viral genome was undetectable in blood samples from 2017-2019, then became detectable at low levels in September 2020 and peaked at very high titers (1010 genome copies/mL) in January 2022. In March 2022, we found >108 genome copies/g or mL in the liver and blood, concomitant with hepatic cytolysis. We detected HCirV-1 transcripts in 2% of hepatocytes, demonstrating viral replication and supporting the role of HCirV-1 in liver damage.

Keywords: France; circoviruses; hepatitis; mNGS; metagenomic next-generation sequencing; solid organ transplants; viruses; zoonoses.

Publication types

  • Case Reports

MeSH terms

  • Circovirus* / genetics
  • Female
  • Genome, Viral
  • Heart-Lung Transplantation*
  • Hepatitis A*
  • Hepatitis*
  • Humans
  • Middle Aged